Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77


How can we predict reversibility of organ dysfunction after implantation of left ventricular assist device?

Fukushima N.

Circ J. 2013;77(1):45-6. Epub 2012 Nov 24. No abstract available.


Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device.

Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, Maki H, Hatano M, Yao A, Nishimura T, Hirata Y, Kyo S, Ono M, Nagai R.

Circ J. 2013;77(1):96-104. Epub 2012 Sep 11.


Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.

Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV; HeartMate II Clinical Investigators.

Circulation. 2009 Dec 8;120(23):2352-7. doi: 10.1161/CIRCULATIONAHA.108.814863. Epub 2009 Nov 23.


Established markers of renal and hepatic failure are not appropriate to predict mortality in the acute stage before extracorporeal life support implantation.

Heilmann C, Trummer G, Berchtold-Herz M, Benk C, Siepe M, Beyersdorf F.

Eur J Cardiothorac Surg. 2012 Jul;42(1):135-41; discussion 141. doi: 10.1093/ejcts/ezr249. Epub 2012 Jan 12.


Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation.

Shiga T, Kinugawa K, Hatano M, Yao A, Nishimura T, Endo M, Kato N, Hirata Y, Kyo S, Ono M, Nagai R.

Circ J. 2011;75(1):121-8. Epub 2010 Nov 23.


Optimal timing of cardiac transplantation after ventricular assist device implantation.

Gammie JS, Edwards LB, Griffith BP, Pierson RN 3rd, Tsao L.

J Thorac Cardiovasc Surg. 2004 Jun;127(6):1789-99.


Changes in renal function after implantation of continuous-flow left ventricular assist devices.

Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS.

J Am Coll Cardiol. 2012 Jan 3;59(1):26-36. doi: 10.1016/j.jacc.2011.09.038.


Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices.

Sandner SE, Zimpfer D, Zrunek P, Dunkler D, Schima H, Rajek A, Grimm M, Wolner E, Wieselthaler GM.

J Heart Lung Transplant. 2008 May;27(5):469-73. doi: 10.1016/j.healun.2007.12.012.


Renal failure following ventricular assist device placement.

Rajagopalan N, Hoopes CW.

J Am Coll Cardiol. 2012 Jun 12;59(24):2220; author reply p. 2220. doi: 10.1016/j.jacc.2012.01.062. No abstract available.


Preoperative risk factors for mortality after biventricular assist device implantation.

Zahr F, Ootaki Y, Starling RC, Smedira NG, Yamani M, Thuita L, Fukamachi K.

J Card Fail. 2008 Dec;14(10):844-9. doi: 10.1016/j.cardfail.2008.08.009. Epub 2008 Oct 14.


[Impact of mechanical circulatory support on renal function in a patient with end stage heart failure].

Urban M, Netuka I, Paríková A, Malý J, Szárszoi O, Pirk J.

Cas Lek Cesk. 2010;149(3):129-32. Czech.


Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement.

Ketchum ES, Moorman AJ, Fishbein DP, Mokadam NA, Verrier ED, Aldea GS, Andrus S, Kenyon KW, Levy WC.

J Heart Lung Transplant. 2010 Sep;29(9):1021-5. doi: 10.1016/j.healun.2010.05.002. Epub 2010 Jun 16.


Prediction of cardiac function after weaning from ventricular assist devices.

Liang H, Lin H, Weng Y, Dandel M, Hetzer R.

J Thorac Cardiovasc Surg. 2005 Dec;130(6):1555-60.


Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.

Rajagopal K, Daneshmand MA, Patel CB, Ganapathi AM, Schechter MA, Rogers JG, Milano CA.

J Thorac Cardiovasc Surg. 2013 May;145(5):1373-9. doi: 10.1016/j.jtcvs.2012.11.066. Epub 2013 Jan 8.


Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device.

Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, Maki H, Hatano M, Yao A, Nishimura T, Hirata Y, Kyo S, Ono M, Nagai R.

Circ J. 2012;76(8):1895-903. Epub 2012 May 23.


Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function.

Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Saito T, Daimon T, Ueno T, Kuratani T, Sawa Y.

Circ J. 2012;76(7):1631-8. Epub 2012 Apr 7.


Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.

Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, Shah AS, Russell SD, Conte JV.

Ann Thorac Surg. 2008 Sep;86(3):832-40; discussion 832-40. doi: 10.1016/j.athoracsur.2008.05.016.


[Ventricular assist support of the failing heart after surgery with extracorporeal circulation].

Rivera Gaitero J, Domínguez Rico E, Plaza Mardomingo A.

Rev Esp Anestesiol Reanim. 2001 Apr;48(4):176-9. Spanish.


Supplemental Content

Support Center